These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11374665)

  • 1. Retreatment of Helicobacter pylori infection after initial treatment failure.
    Kearney DJ
    Am J Gastroenterol; 2001 May; 96(5):1335-9. PubMed ID: 11374665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
    Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
    Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
    J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
    Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
    Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Helicobacter; 2007 Feb; 12(1):68-73. PubMed ID: 17241304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitude facing a patient suffering from Helicobacter pylori infection resistant to a triple therapy.
    Gisbert JP; Pajares JM
    Rev Esp Enferm Dig; 2003 Mar; 95(3):220-8, 210-19. PubMed ID: 12760711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
    Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M
    Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Helicobacter pylori infection.
    Miehlke S; Bayerdörffer E; Graham DY
    Semin Gastrointest Dis; 2001 Jul; 12(3):167-79. PubMed ID: 11478749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
    Buzás GM; Józan J
    Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
    Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A
    Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ranitidine bismuth citrate in the treatment of Helicobacter pylori infection.
    Hergueta Delgado P; Rojas Feria M; Romero Castro R; Mendoza Olivares FJ; Gómez Rodríguez B; Pellicer Bautista FJ; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2002 Jan; 94(1):19-24. PubMed ID: 12073665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
    Tong JL; Ran ZH; Shen J; Xiao SD
    J Clin Pharm Ther; 2009 Feb; 34(1):41-53. PubMed ID: 19125902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Helicobacter pylori.
    Wolle K; Malfertheiner P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):315-24. PubMed ID: 17382279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
    Gisbert JP; Gisbert JL; Marcos S; Pajares JM
    Dig Liver Dis; 2004 Jan; 36(1):7-12. PubMed ID: 14971810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.